Two Sigma Investments’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$50.5K Buy
+10,198
New +$49.6K ﹤0.01% 4452
2022
Q3
Sell
-13,646
Closed -$49K 2798
2022
Q2
$49K Buy
+13,646
New +$69.2K ﹤0.01% 2348

Other funds holding SOPH

Two Sigma Investments's SOPH Position: Q1 2026 in Review

Two Sigma Investments opened a new position in SOPHiA GENETICS (SOPH) in Q1 2026: 10,198 shares worth $50.5K. The stake represents ﹤0.01% of the portfolio and ranks #4452 among its holdings. This is a return to the name: Two Sigma Investments previously reported a position in SOPH as recently as Q2 2022.

Two Sigma Investments first reported a position in SOPH in Q2 2022 and has held it in 2 quarters since. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.

  • Two Sigma Investments held 10,198 shares of SOPHiA GENETICS worth $50.5K as of Q1 2026.
  • SOPHiA GENETICS was a new Two Sigma Investments position in Q1 2026.
  • SOPHiA GENETICS made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4452 holding.
  • Two Sigma Investments first reported a position in SOPHiA GENETICS in Q2 2022 and has held it in 2 quarters since.
  • 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.